Endorsed NICE Clinical Guidelines 2024/2025
Date published:
The following NICE Clinical Guidelines were endorsed by DoH during 2024-2025
Documents
- NG245 - Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) Note this guidance updates and replaces NICE Clinical Guideline NG80 and NICE Technology Appraisals TA131 & 138, which have been previously endorsed by DoH.
- NG243 - Adrenal insufficiency: identification and management.
- NG242 - Diabetic retinopathy: management and monitoring
- NG241 - Ovarian cancer: identifying and managing familial and genetic risk
- NG240 - Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. Note this guidance updates and replaces NICE Clinical Guideline CG102, endorsed by the DoH in May 2011.’
- NG239 - Vitamin B12 deficiency in over 16s: diagnosis and management
- NG237 - Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management. Note this guidance partially updates and replaces NICE Clinical Guideline CG191, endorsed by the DoH in January 2015.